Xcout Intel
KUPANDO competitors & alternatives
The 12 closest competitors and alternatives to KUPANDO among drug discovery companies — ranked by similarity to what KUPANDO actually does, not by market-cap band.
Subscribe to see KUPANDO’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About KUPANDO
Kupando is a pioneering Berlin-based biopharmaceutical and biotech company headquartered in Schönefeld, Germany. The company is focused on the research and clinical development of innovative treatments to fight cancer and infectious diseases.
KUPANDO at a glance
KUPANDO is a drug discovery company headquartered in Germany. Its most recent funding round, Series A, raised $13M in September 2022. Xcout tracks 1 named person at KUPANDO, including Johanna Holldack (CEO).
KUPANDO leadership
- Johanna HolldackCEO
KUPANDO funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $13M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 KUPANDO competitors
Ranked by semantic similarity — how close each company is to KUPANDO by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Ariceum Therapeutics is a radiopharmaceutical company headquartered in Berlin, Germany, with operations across several countries, focused on the development of novel medical treatments.
Similar drug discovery company
Mabsoft Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapeutic solutions, including antibody-drug conjugates and immuno-stimulating antibody conjugates for solid tumors and infectious diseases. The company's pipeline features proprietary candidates such as the antibody-drug conjugate MST-168.
Similar drug discovery company
Smartbax is a biotechnology startup founded in Munich, Germany, in 2021, dedicated to developing innovative next-generation antibiotics to combat the rising threat of multidrug-resistant bacteria.
Similar drug discovery company
Rokote Laboratories is a Finnish biotechnology company founded in 2020 through a collaboration between the University of Helsinki and the University of Eastern Finland to develop innovative medical treatments.
Similar drug discovery company
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
Similar drug discovery company
Peptomyc is a clinical-stage biotechnology company headquartered in Barcelona, Spain, specializing in the development of protein and peptide therapeutics for cancer.
Similar drug discovery company
Founded in 2021 and headquartered in Shenzhen, China, MagicRNA Biotechnology Co., Ltd. is a clinical-stage biotechnology company focused on nucleic acid drug delivery and the research and development of next-generation mRNA and lipid nanoparticle technologies for the treatment of cancer and infectious diseases.
Similar drug discovery company
Versameb AG is a privately held biopharmaceutical company focused on discovering and developing innovative RNA-based therapeutics.
Similar drug discovery company
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Biopharmaceuticals
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
Biopharmaceuticals
Chimerix, Inc. is a biopharmaceutical company that develops medicines for oncology and other critical illnesses, serving US-based healthcare audiences and patients.
Biopharmaceuticals
Glionova AB is a Sweden-based, development-stage biopharmaceutical company founded in 2014 that focuses on developing cancer prevention therapies and treatments for difficult-to-treat cancers. The company's pipeline includes small-molecule oncolytic drugs, featuring its lead candidate GLN-1001.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of KUPANDO and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for KUPANDOand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →